Synovus Financial Corp financial data

Symbol
SNV, SNV-PD, SNV-PE on NYSE
Industry
National Commercial Banks
Location
33 W 14 Th Street, Columbus, GA
State of incorporation
US
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 1.06K % -8.69%
Return On Equity 9.29 % -17.6%
Return On Assets 0.81 % -10%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 141M shares -3.79%
Common Stock, Shares, Outstanding 141M shares -3.78%
Entity Public Float 5.51B USD +30.8%
Common Stock, Value, Issued 172M USD +0.48%
Weighted Average Number of Shares Outstanding, Basic 144M shares -1.34%
Weighted Average Number of Shares Outstanding, Diluted 145M shares -1.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 606M USD -41.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 605M USD -13.1%
Income Tax Expense (Benefit) 126M USD -18.5%
Net Income (Loss) Attributable to Parent 482M USD -11.3%
Earnings Per Share, Basic 3.05 USD/shares -12.4%
Earnings Per Share, Diluted 3.03 USD/shares -12.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 480M USD 0%
Assets 60.2B USD +0.71%
Liabilities 55B USD +0.55%
Accumulated Other Comprehensive Income (Loss), Net of Tax -971M USD +13.1%
Retained Earnings (Accumulated Deficit) 2.74B USD +8.7%
Stockholders' Equity Attributable to Parent 5.24B USD +2.43%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.27B USD +2.37%
Liabilities and Equity 60.2B USD +0.71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 24.1M USD -93.2%
Net Cash Provided by (Used in) Financing Activities 26.3M USD -98.5%
Net Cash Provided by (Used in) Investing Activities -78.3M USD +88.7%
Common Stock, Shares Authorized 343M shares 0%
Common Stock, Shares, Issued 172M shares +0.48%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -27.9M USD -102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.99B USD +22.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 385M USD +86.4%
Deferred Tax Assets, Valuation Allowance 27.5M USD +4.96%
Deferred Tax Assets, Gross 673M USD -7.47%
Payments to Acquire Property, Plant, and Equipment 18.5M USD +184%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 629M USD -27.6%
Deferred Income Tax Expense (Benefit) 2.45M USD +246%
Deferred Tax Assets, Operating Loss Carryforwards 32.5M USD +1.2%
Preferred Stock, Shares Issued 22M shares 0%
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 21.7M USD -2.83%
Additional Paid in Capital 3.99B USD +0.78%
Amortization of Intangible Assets 3M USD +42.9%
Deferred Tax Assets, Net of Valuation Allowance 646M USD -7.94%
Interest Expense 1.36B USD +177%